BioCryst Pharmaceuticals
BCRX
BCRX
206 hedge funds and large institutions have $1.62B invested in BioCryst Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 74 increasing their positions, 55 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
206
Holders Change
+9
Holders Change %
+4.57%
% of All Funds
3.18%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
38
Increased
74
Reduced
55
Closed
29
Calls
$77.9M
Puts
$38.7M
Net Calls
+$39.2M
Net Calls Change
+$1.69M
Top Buyers
Top Sellers
| 1 |
HM
HealthCor Management
New York
|
$32.9M |
| 2 |
Two Sigma Investments
New York
|
$16.9M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
$668K |
| 4 |
Northern Trust
Chicago,
Illinois
|
$25.8M |
| 5 |
Citadel Advisors
Miami,
Florida
|
$5.52M |
